Muna Qayed retweeted
The Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta is hosting the 2025 Sickle Cell Transplant Advocacy & Research Alliance (STAR) Annual Meeting. We are honored to bring together hematologists and transplant physicians for this important 2-day event.
Muna Qayed retweeted
CONGRESS | #Tandem25
@MunaQayed, @EmoryUniversity discussed the impact of #GvHD on leukemia-free survival. In this study, GvHD did not reduce relapse risk in #ALL or #AML, and severe aGvHD led to inferior OS.
gvhdhub.com/medical-informat…
Muna Qayed retweeted
In the midst of an extremely difficult period, Lamya and I are walking to help support our university and the communities it serves. #AUB4BeirutRun2024
Excited for a new phase of caring for children and a new #AtlBMT unit at @childrensatl Arthur M. Blank Hospital. Bittersweet goodbye to the Egleston campus.
@ATLPedsHemOnc
Important Reminder! 📣 Arthur M. Blank Hospital is opening its doors this Sunday, September 29, 2024. Thank you for your understanding as we transfer patients—please yield to ambulances near our hospitals. For more information, please visit: choa.org/future.
Great to see everyone and to make new friends at the first @AAACTT_org conference. Thank you to our wonderful hosts @KHCFKHCC #bmtsm
@ASamerAlHomsi1 @usamagergis @MKD_BMT @RabiHannaMD @rawadrihani @DrM_AbuZaid @DrMonzrAlMalki @aymansaadOSU @Razan_Mohty @NChokr @hhashem84
Excited to hear @MunaQayed present #GVHD prophylaxis in mismatch unrelated and #Haplo-HCT during @AAACTT_org conference at @KHCFKHCC
Muna Qayed retweeted
🎙️Had a great convo with @ASamerAlHomsi1 regarding the novel PTCy + abatacept + short course tacrolimus (#CAST regimen) - a potential game changer in #GVHD prophylaxis and perhaps next evolution of #PTCyRules.
Also first time hosting @ASTCT Talks! I hope you enjoy!🙏
podcasters.spotify.com/pod/s…
Muna Qayed retweeted
A validated risk stratification that incorporates MAGIC biomarkers predicts long-term outcome in pediatric patients with acute #GVHD. Biomarker-based risk stratification can be used in clinical trials to develop methods for children who require treatment. ow.ly/7ob650SeFy4
I'm excited to share that the @Incyte Ingenuity Awards in GVHD is accepting applications! This program supports unique proposals, like mine, that address specific needs of the graft-versus-host disease (#GVHD) community. If you have an idea, apply today: bit.ly/49DZfos
At least once a year I have my @aflac ducks in a row… each duck = 1 year at @ATLPedsHemOnc
Another successful #ASH23 for the @ATLPedsHemOnc team. @DouglasKGraham @vivien_liv @thewaitman @kmwilliamsATL @BloodDoc2
Muna Qayed retweeted
Ready to address barriers in #HCT and #celltherapy? Join us and @ASTCT on Oct. 17 to explore strategies to improve patient access and outcomes regardless of race, ethnicity or socioeconomic status. Plus, earn CME credit. Save your spot 👉 bit.ly/46qcuHq
Celebrating the successes of @EmoryVascSurg and VA faculty @OAlabiMD graduating #EmoryMSCR @EmoryRollins
#alwayslearning @Georgia_CTSA @WovasS @Dr_Katie_Hekman
Heat hills and humidity at @ajcprr nowhere else I’d rather be! @ATLtrackclub
Happy 4th of July!
Muna Qayed retweeted
#EBMT23 | @Razan_Mohty (@MoffittNews) discusses a study evaluating a novel composite endpoint of toxicity and PFS in patients with R/R follicular lymphoma treated with axi-cel.
Watch now:
👉ow.ly/cign50One8k👈
@TheEBMT #LymSM #CARTcell #ImmunoOnc
Great results from @ASamerAlHomsi1 combining PTCy and Abatacept with low rates of acute and chronic GVHD
PTCy, Abatacept and Short Course Tacrolimus, a feasible combination for acute GVHD prevention following haploidentical PB transplantations.
‘CAST regimen’
ashpublications.org/bloodadv…
Muna Qayed retweeted
#ASPHO2033 #PHODocs #jobs
Come work with us at @ATLPedsHemOnc!
We are looking for:
- #BMT #Hospitalist
- #Cancer #Epidemiologist
- #Hemostasis/#Thrombosis #BasicScientist
- others!
👉CHOA.org/careers
